NovoNordisk's GLP-1 semaglutide drug, Rybelsus pill FDA approved to reduce heart attacks, strokes, cardiovascular death in type 2 diabetics.
DoctorPodcasts EPISODE 128:#NovoNordisk's #GLP-1 #semaglutide #Rybelsus pill just got FDA approval to cut heart attacks & strokes by 14% in type 2 diabetics. It's the first pill with …